High Acceptability of HIV Pre-Exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights From a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya

AIDS and Behavior - Netherlands
doi 10.1007/s10461-012-0317-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana

World Journal of AIDS
2015English

Intimate Partner Violence and Adherence to HIV Pre-Exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

The Mutable Dynamics of HIV-Prevention: Insights From Ontarian MSM on Pre-Exposure Prophylaxis (PrEP)

English

O16.3 Loss to Follow-Up and Patient Self-Discontinuation of Hiv Pre-Exposure Prophylaxis (PREP) in an STD Clinic-Based Prep Program With Adherence Support

2017English

Portuguese Health Care Providers’ Knowledge, Attitudes, and Acceptability of HIV Pre-Exposure Prophylaxis

HIV and AIDS Review
EpidemiologyInfectious Diseases
2018English

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study

PLoS ONE
Multidisciplinary
2013English

Strong Relationship Between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)

PLoS ONE
Multidisciplinary
2014English

“I Am Still Negative”: Female Sex Workers’ Perspectives on Uptake and Use of Daily Pre-Exposure Prophylaxis for HIV Prevention in South Africa

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy